S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
The perfect AI stock under $10 (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Billionaires Are Now FLOODING Into Gold (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
The perfect AI stock under $10 (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Billionaires Are Now FLOODING Into Gold (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
The perfect AI stock under $10 (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Billionaires Are Now FLOODING Into Gold (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
S&P 500   4,975.51
DOW   38,563.80
QQQ   427.32
Higher VIX just made Realty Income’s 6% dividend better
The perfect AI stock under $10 (Ad)
Super Micro Computer: Overbought, undervalued or mispriced?
Booking stock is the discounted growth story in travel stocks
Billionaires Are Now FLOODING Into Gold (Ad)
3 E-VTOL stocks: Which ones can fly higher in 2024?
Capital One's bid for Discover carries expectation that Americans won't slow credit card use
Elon Musk's "Project Dojo" is a Game-Changer (Ad)
Walmart’s uptrend is intact; buy it when it dips
XPeng stock just got a target boost, analysts say it could double
NASDAQ:NTUS

Natus Medical (NTUS) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$32.96
$32.96
50-Day Range
$32.96
$32.96
52-Week Range
$20.90
$33.93
Volume
1,514 shs
Average Volume
325,002 shs
Market Capitalization
$1.14 billion
P/E Ratio
89.08
Dividend Yield
N/A
Price Target
N/A

NTUS stock logo

About Natus Medical Stock (NASDAQ:NTUS)

Natus Medical Incorporated provides medical device solutions focuses on the diagnosis and treatment of patients with central nervous and sensory system disorders worldwide. It offers products and technologies used for the screening, detection, treatment, monitoring, and tracking of common medical ailments in newborn care, hearing impairment, neurological and neurosurgical treatments, epilepsy, sleep disorders, and neuromuscular diseases. The company also provides computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology; and software systems for managing and tracking disorders and diseases for public health laboratories. In addition, it offers electroencephalography, long term monitoring, intensive care unit monitoring, electromyography, sleep analysis or polysomnography, and intra-operative monitoring solutions. Further, the company provides hearing assessment, screening, and instrument fitting solutions; jaundice management products; brain injury products; and eye imaging systems and products used in the advanced science and practice of neonatal and pediatric retinal imaging. Additionally, it offers essential products used in the everyday operation of neonatal intensive care unit (NICU); balance assessment systems to evaluate patients with balance disorders; and NICVIEW, a live streaming video for families with babies in the NICU. The company also provides computer-based audiological, otoneurologic, and vestibular instrumentation for hearing and balance care professionals. It serves university medical centers, public and private hospitals, physician offices, clinics, research laboratories, and others. The company was formerly known as ALGOTEK Instruments, Inc. and changed its name to Natus Medical Incorporated in September 1988. Natus Medical Incorporated was incorporated in 1987 and is headquartered in Middleton, Wisconsin.


NTUS Stock News Headlines

Natus Medical Incorporated
AI Stock Caught Trading Under Secret Name
We have uncovered perhaps the most unusual AI stock we've ever seen.It's expected to see massive revenue this year - $215 billion.  The company holds over 29,000 patents in the U.S. It pays an enormous dividend.
The perfect AI stock under $10
Normally, bringing a new drug to market takes an average of 10 years and between $2.5 and $12 billion. However, new AI technology has the potential to make the process up to 1000 times faster. This #1 AI company is at the forefront of it all.
See More Headlines
Receive NTUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Natus Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/04/2021
Today
2/20/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical Equipment
Sub-Industry
N/A
Current Symbol
NASDAQ:NTUS
Employees
1,400
Year Founded
N/A

Profitability

Net Income
$13.18 million
Pretax Margin
4.15%

Debt

Sales & Book Value

Annual Sales
$473.44 million
Cash Flow
$2.02 per share
Book Value
$12.44 per share

Miscellaneous

Free Float
34,166,000
Market Cap
$1.14 billion
Optionable
Optionable
Beta
0.22
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Thomas Joseph Sullivan (Age 58)
    Pres, CEO & Director
    Comp: $17.27k
  • Mr. Benjamin Drew Davies (Age 56)
    Exec. VP & CFO
    Comp: $812.16k
  • Mr. Austin F. Noll III (Age 55)
    Exec. VP & Chief Commercial Officer
    Comp: $756.19k
  • Mr. Seán Langan
    VP of Global Operations
  • Mr. Ivan Pandiyan
    VP of Global R&D
  • Mr. Douglas Balog
    VP, Gen. Counsel & Sec.
  • Ms. Lisa Paul (Age 58)
    Chief People Officer & VP














NTUS Stock Analysis - Frequently Asked Questions

How were Natus Medical's earnings last quarter?

Natus Medical Incorporated (NASDAQ:NTUS) released its quarterly earnings data on Thursday, November, 4th. The company reported $0.28 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.30 by $0.02. The company had revenue of $113.88 million for the quarter, compared to the consensus estimate of $116.60 million. Natus Medical had a trailing twelve-month return on equity of 10.15% and a net margin of 2.65%. During the same period last year, the company earned $0.09 EPS.

What other stocks do shareholders of Natus Medical own?
This page (NASDAQ:NTUS) was last updated on 2/21/2024 by MarketBeat.com Staff